Designing porous silicon-based microparticles as carriers for controlled delivery of mitoxantrone dihydrochloride

Journal of Materials Research

Volumn 28, Issue 2, 2013, Pages 231-239

  Tzur Balter, Adi ^a   Rubinski, Anna ^a   Segal, Ester ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

1-DODECENE; ANTICANCER DRUG; ATTENUATED TOTAL REFLECTANCE FOURIER TRANSFORM INFRARED SPECTROSCOPY; CHEMICALLY MODIFIED; CONTROLLED DELIVERY; COVALENT ATTACHMENT; CYTOTOXIC; DRUG LOADING; DRUG RELEASE; HUMAN BREAST; IN-VITRO; LOW TOXICITY; MICRO-PARTICLES; MITOXANTRONE; NANO-STRUCTURED; NITROGEN ADSORPTION-DESORPTION; PHYSICAL ADSORPTION; PHYSIO-CHEMICAL PROPERTIES; SILICON-BASED; UNDECANOIC ACID; UNDECYLENIC ACID;

ADSORPTION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HYDROSILYLATION; POROUS SILICON; SATURATED FATTY ACIDS; SURFACE CHEMISTRY;

CYTOTOXICITY;

EID: 84873859002     PISSN: 08842914     EISSN: 20445326     Source Type: Journal    
DOI: 10.1557/jmr.2012.299     Document Type: Article

References (37)

1. L.M. Bonanno and E. Segal: Nanostructured porous silicon-polymerbased hybrids: From biosensing to drug delivery. Nanomedicine 6(10), 1755 (2011).
2. L.M. Bimbo, M. Sarparanta, H.A. Santos, A.J. Airaksinen, E. Makila, T. Laaksonen, L. Peltonen, V.P. Lehto, J. Hirvonen, and J. Salonen: Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. ACS Nano 4(6), 3023 (2010).
3. J. Salonen, A.M. Kaukonen, J. Hirvonen, and V.P. Lehto:Mesoporous silicon in drug delivery applications. J. Pharm. Sci. 97(2), 632 (2008).
4. P. Kinnari, E. Makila, T. Heikkila, J. Salonen, J. Hirvonen, and H.A. Santos: Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole. Int. J. Pharm. 414(1-2), 148 (2011).
5. X. Li, J.S. John, J.L. Coffer, Y. Chen, R.F. Pinizzotto, J. Newey, C. Reeves, and L.T. Canham: Porosified silicon wafer structures impregnated with platinum anti-tumor compounds: Fabrication, characterization, and diffusion studies. Biomed. Microdevices 2, 265 (2000).
6. J.H. Park, L. Gu, G. von Maltzahn, E. Ruoslahti, S.N. Bhatia, and M.J. Sailor: Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 8(4), 331 (2009).
7. L.A. Perelman, C. Pacholski, Y.Y. Li, M.S. VanNieuwenhze, and M.J. Sailor: pH-triggered release of vancomycin from protein-capped porous silicon films. Nanomedicine (Lond) 3(1), 31 (2008).
8. J. Salonen, L. Laitinen, A.M. Kaukonen, J. Tuura, M. Bjorkqvist, T. Heikkila, K. Vaha-Heikkila, J. Hirvonen and V.P. Lehto: Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs. J. Controlled Release 108(2-3), 362 (2005).
9. H.A. Santos, J. Salonen, L.M. Bimbo, V.P. Lehto, L. Peltonen, and J. Hirvonen: Mesoporous materials as controlled drug delivery formulations. J. Drug Delivery Sci. Technol. 21(2), 139 (2011).
10. L.T. Canham: Bioactive silicon structure fabrication through nanoetching techniques. Adv. Mater. 7(12), 1033 (1995).
11. J.P.S. McInnes and N.H. Voelcker: Silicon-polymer hybrid materials for drug delivery. Future Med. Chem. 1, 1051 (2009).
12. N. Artzi, N. Oliva, C. Puron, S. Shitreet, S. Artzi, A. Bon Ramos, A. Groothuis, G. Sahagian, and E.R. Edelman: In vivo and in vitro tracking of erosion in biodegradable materials using non-invasive fluorescence imaging. Nat. Mater. 10, 704 (2011).
13. B. Godin, J.H. Gu, R.E. Serda, R. Bhavane, E. Tasciotti, C. Chiappini, X.W. Liu, T. Tanaka, P. Decuzzi, and M. Ferrari: Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J. Biomed. Mater. Res. Part A 94A, 1236 (2010).
14. L.T. Canham,M.P. Stewart, J.M. Buriak, C.L. Reeves,M.Anderson, E.K. Squire, P. Allcock, and P.A. Snow: Derivatized porous silicon mirrors: Implantable optical components with slow resorbability. Phys. Status Solidi A 182(1), 521 (2000).
15. E.J. Anglin, L.Y. Cheng, W.R. Freeman, and M.J. Sailor: Porous silicon in drug delivery devices and materials. Adv. Drug Delivery Rev. 60(11), 1266 (2008).
16. J.C. Doughty, E. Kane, T.G. Cooke, and C.S. McArdle: Mitoxantrone and methotrexate chemotherapy with and without mitomycin C in the regional treatment of locally advanced breast cancer. Breast 11(1), 97 (2002).
17. F. Hagemeister, F. Cabanillas, M. Coleman, S.A. Gregory, and P.L. Zinzani: The role of mitoxantrone in the treatment of indolent lymphomas. The Oncologist 10(2), 150 (2005).
18. S. Brunauer, P.H. Emmett, and E. Teller: Adsorption of gases in multimolecular layers. J. Am. Chem. Soc. 60(309), (1938).
19. S.J. Gregg and K.S.W. Sing: Adsorption, Surface Area and Porosity (Academic, London, 1982).
20. E. Segal, L.A. Perelman, F. Cunin, F. Di Renzo, J.M. Devoisselle, Y.Y. Li, and M.J. Sailor: Confinement of thermoresponsive hydrogels in nanostructured porous silicon dioxide templates. Adv. Funct. Mater. 17(7), 1153 (2007).
21. H.A. Santos, J. Riikonen, J. Salonen, E. Makila, T. Heikkila, T. Laaksonen, L. Peltonen, V.P. Lehto, and J. Hirvonen: In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size. Acta Biomater. 6(7), 2721 (2010).
22. J. Salonen and V.P. Lehto: Fabrication and chemical surface modification of mesoporous silicon for biomedical applications. Chem. Eng. J. 137, 162 (2008).
23. L.M. Bimbo, E. Mäkiläb, T. Laaksonen, V-P. Lehto, J. Salonen, J. Hirvonen, and H.A. Santos: Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. Biomaterials 32(10), 2625 (2011).
24. C. Chiappini, E. Tasciotti, J.R. Fakhoury, D. Fine, L. Pullan, Y-C. Wang, L. Fu, X. Liu, and M. Ferrari: Tailored porous silicon microparticles: Fabrication and properties. ChemPhysChem 11(5), 1029 (2010).
25. S.D. Alvarez, A.M. Derfus, M.P. Schwartz, S.N. Bhatia, and M.J. Sailor: The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors. Biomaterials 30(1), 26 (2009).
26. M.P. Schwartz, F. Cunin, R.W. Cheung, and M.J. Sailor: Chemical modification of silicon surfaces for biological applications. Phys. Status Solidi A 202(8), 1380 (2005).
27. K.L. Jarvis, T.J. Barnes, A. Badalyan, P. Pendleton, and C.A. Prestidge: Impact of thermal oxidation on the adsorptive properties and structure of porous silicon particles. J. Phys. Chem. C, 112, 9717 (2008).
28. E.J. Anglin, M.P. Schwartz, V.P. Ng, L.A. Perelman, and M.J. Sailor: Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid. Langmuir 20(25), 11264 (2004).
29. E.C. Wu, J.H. Park, J. Park, E. Segal, F. Cunin, and M.J. Sailor: Oxidation-triggered release of fluorescent molecules or drugs from mesoporous Si microparticles. ACS Nano 2(11), 2401 (2008).
30. M. Kovalainen, J. Mönkäre, E. Mäkilä, J. Salonen, V.P. Lehto, K.H. Herzig, and H. Järvinen: Mesoporous silicon (PSi) for sustained peptide delivery: Effect of PSi microparticle surface chemistry on peptide YY3-36 release. Pharm. Res. 29, 837 (2012).
31. M. Kovalainen, J. Mönkäre, E. Mäkilä, J. Salonen, V.P. Lehto, K.H. Herzig, and H. Järvinen: Mesoporous silicon (PSi) for sustained peptide delivery: Effect of PSi microparticle surface chemistry on peptide YY3-36 release. Pharm. Res. 29, 837 (2012).
32. E.C. Wu, J.S. Andrew, L.Y. Cheng, W.R. Freeman, L. Pearson, and M.J. Sailor: Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles. Biomaterials 32(7), 1957 (2011).
33. B. Godin, J.H. Gu, R.E. Serda, R. Bhavane, E. Tasciotti, C. Chiappini, X.W. Liu, T. Tanaka, P. Decuzzi, and M. Ferrari: Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J. Biomed. Mater. Res. Part A 94A(4), 1236 (2010).
34. D.L. Wise: Handbook of Pharmaceutical Controlled Release Technology, 1st ed. (Marcel Dekker Inc., New York, 2000).
35. K.A. Kilian, T. Booking, K. Gaus, M. Gal, and J.J. Gooding: Si-C linked oligo(ethylene glycol) layers in silicon-based photonic crystals: Optimization for implantable optical materials. Biomaterials 28(20), 3055 (2007).
36. J. O'Brien and F. Pognan: Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Toxicology 164(1-3), 132 (2001).
37. L. Cheng, E. Anglin, F. Cunin, D. Kim, M.J. Sailor, I. Falkenstein, A. Tammewar, and W.R. Freeman: Intravitreal properties of porous silicon photonic crystals: A potential self-reporting intraocular drug-delivery vehicle. Br. J. Ophthalmol. 92(5), 705 (2008).